Background: The adenoma detection rate (ADR) is an essential quality indicator for endoscopists performing colonoscopies for colorectal cancer (CRC) screening as it is associated with postcolonoscopy CRCs (PCCRCs). Currently, data on ADRs of endoscopists performing colonoscopies in fecal immunochemical testing (FIT)-based screening, the most common screening method, are scarce. Also, the association between the ADR and PCCRC has not been demonstrated in this setting.
Objective: To evaluate the association between the ADR and PCCRC risk in colonoscopies done after a positive FIT result.
Design: Population-based cohort.
Setting: Dutch, FIT-based, CRC screening program.
Participants: Patients undergoing colonoscopy, done by accredited endoscopists, after a positive FIT result.
Measurements: Quality indicator performance and PCCRC incidence for colonoscopies in FIT-positive screenees were assessed. The PCCRCs were classified as interval, a cancer detected before recommended surveillance, or noninterval. The association between ADR and interval PCCRC was evaluated with a multivariable Cox regression model and PCCRC incidence was determined for different ADRs.
Results: 362 endoscopists performed 116 360 colonoscopies with a median ADR of 67%. In total, 209 interval PCCRCs were identified. The ADR was associated with interval PCCRC, with an adjusted hazard ratio of 0.95 (95% CI, 0.92 to 0.97) per 1% increase in ADR. For every 1000 patients undergoing colonoscopy, the expected number of interval PCCRC diagnoses after 5 years was approximately 2 for endoscopists with ADRs of 70%, compared with more than 2.5, almost 3.5, and more than 4.5 for endoscopists with ADRs of 65%, 60%, and 55%, respectively.
Limitation: The relative short duration of follow-up (median, 52 months) could be considered a limitation.
Conclusion: The ADR of endoscopists is inversely associated with the risk for interval PCCRC in FIT-positive colonoscopies. Endoscopists performing colonoscopy in FIT-based screening should aim for markedly higher ADRs compared with primary colonoscopy.
Primary Funding Source: None.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7326/M22-0301 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Costs and benefits of a formal quality framework for colonoscopy: Economic evaluation.
Endosc Int Open
November 2024
Department of Gastroenterology and Hepatology, Queensland Health - Princess Alexandra Hospital, Brisbane, Australia.
Reduction of colorectal cancer morbidity and mortality is one of the primary objectives of colonoscopy. Post-colonoscopy colorectal cancers (PCCRCs) are critical outcome parameters. Analysis of PCCRC rates can validate quality assurance measures in colonoscopy.
View Article and Find Full Text PDFSystematic Review and Meta-analysis: The Three-year Post-colonoscopy Colorectal Cancer Rate as per the World Endoscopy Organization Methodology.
Clin Gastroenterol Hepatol
August 2024
Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS), University College London (UCL), London, United Kingdom.
Article Synopsis
- In 2018, the World Endoscopy Organization (WEO) established standardized methods to calculate post-colonoscopy colorectal cancer rates over three years (PCCRC-3yr), prompting a systematic review to assess global rates and associated risk factors.
- The review analyzed studies from five databases and included eight studies totaling over 220,000 colorectal cancer cases, finding a pooled PCCRC-3yr rate of 7.5% that significantly decreased from 7.9% in 2006 to 6.7% in 2012.
- Higher PCCRC rates were linked to specific risk factors, including inflammatory bowel disease, prior colorectal cancer, proximal cancer location, diverticular disease, and being female, undersc
Preventable Predictive Factors of Post-colonoscopy Colorectal Cancer in Inflammatory Bowel Disease.
J Crohns Colitis
January 2025
Gastroenterology Unit, Policlinico Universitario Tor Vergata, Rome, Italy.
Background And Aim: Post-colonoscopy colorectal cancer [PCCRC] is a colorectal cancer [CRC] diagnosed after a colonoscopy in which no cancer was detected [index colonoscopy]. Although the overall cumulative rates of PCCRC are low in both the general population and inflammatory bowel disease [IBD] patients, the overall incidence of PCCRC in IBD is greater than that documented in the general population. This study aimed to identify the index colonoscopy-related factors and patients' characteristics influencing IBD-associated PCCRC development.
View Article and Find Full Text PDFImpact of Bowel Preparation Quality on Colonoscopy Findings and Colorectal Cancer Deaths in a Nation-Wide Colorectal Cancer Screening Program.
Am J Gastroenterol
October 2024
Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
Introduction: Adequate bowel preparation is paramount for a high-quality screening colonoscopy. Despite the importance of adequate bowel preparation, there is a lack of large studies that associated the degree of bowel preparation with long-term colorectal cancer outcomes in screening patients.
Methods: In a large population-based screening program database in Austria, quality of bowel preparation was estimated according to the Aronchick Scale by the endoscopist (excellent, good, fair, poor, and inadequate bowel preparation).
Type 2 diabetes mellitus and post-colonoscopy colorectal cancer: clinical and molecular characteristics and survival.
Cancer Causes Control
July 2024
Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.
Purpose: Studies suggest that patients with type two diabetes mellitus (T2D) may be at increased risk of post-colonoscopy colorectal cancer (PCCRC). We investigated clinical and molecular characteristics and survival of T2D patients with PCCRC to elucidate how T2D-related PCCRC may arise.
Methods: We identified T2D patients with colorectal cancer (CRC) from 1995 to 2015 and computed prevalence ratios (PRs) comparing clinical and molecular characteristics of CRC in T2D patients with PCCRC vs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!